Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1983 1
1985 2
1987 3
1988 2
1989 2
1990 4
1991 7
1992 2
1996 2
1997 1
1998 1
1999 3
2000 2
2001 3
2002 4
2003 5
2004 4
2005 2
2006 11
2007 6
2008 7
2009 5
2010 11
2011 14
2012 17
2013 13
2014 16
2015 8
2016 22
2017 15
2018 17
2019 14
2020 8
2021 7
2022 16
2023 8
2024 3
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

242 results

Results by year

Filters applied: . Clear all
Page 1
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP).
Tsuji BT, Pogue JM, Zavascki AP, Paul M, Daikos GL, Forrest A, Giacobbe DR, Viscoli C, Giamarellou H, Karaiskos I, Kaye D, Mouton JW, Tam VH, Thamlikitkul V, Wunderink RG, Li J, Nation RL, Kaye KS. Tsuji BT, et al. Among authors: thamlikitkul v. Pharmacotherapy. 2019 Jan;39(1):10-39. doi: 10.1002/phar.2209. Pharmacotherapy. 2019. PMID: 30710469 Free PMC article.
Dosing guidance for intravenous colistin in critically-ill patients.
Nation RL, Garonzik SM, Thamlikitkul V, Giamarellos-Bourboulis EJ, Forrest A, Paterson DL, Li J, Silveira FP. Nation RL, et al. Among authors: thamlikitkul v. Clin Infect Dis. 2017 Mar 1;64(5):565-571. doi: 10.1093/cid/ciw839. Epub 2016 Dec 23. Clin Infect Dis. 2017. PMID: 28011614 Free PMC article. Clinical Trial.
Colistin Monotherapy versus Combination Therapy for Carbapenem-Resistant Organisms.
Kaye KS, Marchaim D, Thamlikitkul V, Carmeli Y, Chiu CH, Daikos G, Dhar S, Durante-Mangoni E, Gikas A, Kotanidou A, Paul M, Roilides E, Rybak M, Samarkos M, Sims M, Tancheva D, Tsiodras S, Kett D, Patel G, Calfee D, Leibovici L, Power L, Munoz-Price S, Stevenson K, Susick L, Latack K, Daniel J, Chiou C, Divine GW, Ghazyaran V, Pogue JM. Kaye KS, et al. Among authors: thamlikitkul v. NEJM Evid. 2023 Jan;2(1):10.1056/evidoa2200131. doi: 10.1056/evidoa2200131. Epub 2022 Dec 6. NEJM Evid. 2023. PMID: 37538951 Free PMC article.
Melioidosis.
Bovornkitti S, Leelarasamee A, Thamlikitkul V. Bovornkitti S, et al. Among authors: thamlikitkul v. Arch Monaldi. 1985 Sep-Dec;40(5-6):203-10. Arch Monaldi. 1985. PMID: 3843170 No abstract available.
Pneumococcal vaccine.
Thamlikitkul V. Thamlikitkul V. Asian Pac J Allergy Immunol. 1985 Dec;3(2):221-5. Asian Pac J Allergy Immunol. 1985. PMID: 3907653 Free article. Review. No abstract available.
Population Pharmacokinetics of Polymyxin B.
Manchandani P, Thamlikitkul V, Dubrovskaya Y, Babic JT, Lye DC, Lee LS, Tam VH. Manchandani P, et al. Among authors: thamlikitkul v. Clin Pharmacol Ther. 2018 Sep;104(3):534-538. doi: 10.1002/cpt.981. Epub 2018 Jan 8. Clin Pharmacol Ther. 2018. PMID: 29238962
High burden of antimicrobial drug resistance in Asia.
Lai CC, Lee K, Xiao Y, Ahmad N, Veeraraghavan B, Thamlikitkul V, Tambyah PA, Nelwan RH, Shibl AM, Wu JJ, Seto WH, Hsueh PR. Lai CC, et al. Among authors: thamlikitkul v. J Glob Antimicrob Resist. 2014 Sep;2(3):141-147. doi: 10.1016/j.jgar.2014.02.007. Epub 2014 Mar 28. J Glob Antimicrob Resist. 2014. PMID: 27873720 Review.
The Impact of Synergistic Therapy Between Colistin and Meropenem on Outcomes of Patients With Pneumonia or Bloodstream Infection Due to Carbapenem-Resistant Gram-Negative Pathogens.
Huralska M, Pogue JM, Rybak M, Abdul-Mutakabbir JC, Stamper K, Marchaim D, Thamlikitkul V, Carmeli Y, Chiu CH, Daikos G, Dhar S, Durante-Mangoni E, Gikas A, Kotanidou A, Paul M, Roilides E, Samarkos M, Sims M, Tancheva D, Tsiodras S, Kett DH, Patel G, Calfee DP, Leibovici L, Power L, Munoz-Price S, Shaikh H, Susick L, Latack K, Chiou C, Divine G, Ghazyaran V, Kaye KS. Huralska M, et al. Among authors: thamlikitkul v. Clin Infect Dis. 2025 Jul 19:ciaf398. doi: 10.1093/cid/ciaf398. Online ahead of print. Clin Infect Dis. 2025. PMID: 40682801
242 results